Directa Plus to present at Mello London

RNS Number : 3907I
Directa Plus PLC
23 November 2018
 

23 November 2018

 

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Directa Plus to present at Mello London

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that it will be exhibiting and presenting at the Mello London investor event, being held on Monday, 26 November 2018 at the Clayton Hotel, Chiswick High Road, London W4 5RY. 

Giulio Cesareo, Chief Executive Officer, and Marco Ferrari, Chief Financial Officer, will be presenting from 2:20pm - 3pm on that day, and will be hosting an exhibition stand throughout the day.

The presentation materials will be available on the Company's website following the event. No new material information will be disclosed.

For information on the event and ticket availability, please visit the event website at http://melloevents.com/mello-london/ 

For further information please visit http://www.directa-plus.com/ or contact:

 

+39 02 36714458

 

 

 

+44 20 7894 7000

 

 

 

+44 20 7496 3069

 

 

+44 20 7920 3150

 

 

About Directa Plus

Directa Plus is principally focussed on the two sectors in which it has a strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products).  In addition, the Company will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using G+ products.  All Directa Plus products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEXLFLVFFEFBV
UK 100

Latest directors dealings